Related Experiment Video
Updated: Aug 6, 2026

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Plasma menthol delivery from a heated tobacco product predicts substitution for menthol cigarettes
Augustus M White1, Tore Eid2, Rabia Imran3
1Virginia Commonwealth University, Richmond, VA, United States; Vanderbilt University Medical Center, Nashville, TN, United States.
Background:
Substitution between tobacco products depends on similarity in abuse liability profiles, particularly pharmacologic reinforcement. While nicotine delivery has been extensively characterized in the literature, the contribution of menthol delivery remains poorly understood. This study examined menthol exposure from a heated tobacco product (IQOS) and assessed whether plasma menthol delivery predicts willingness to substitute it for menthol cigarettes.
Methods:
This exploratory analysis used data from a randomized, parallel-group, 14-day clinical trial of adults who smoke menthol cigarettes (N = 22). Participants used their own-brand menthol cigarettes (Week 1), then were randomized to use IQOS with Fresh Menthol (IQOS-M) or Regular/Tobacco (IQOS-T) HeatSticks (Week 2). Plasma nicotine and menthol glucuronide were measured before and after a laboratory-based 10-puff directed use bout. Substitution was assessed via the cross-price elasticity (CPE) of IQOS relative to menthol cigarettes in the Experimental Tobacco Marketplace task.
Results:
IQOS-M boosted plasma menthol glucuronide levels more than IQOS-T (18.9 versus 0.2ng/mL, p < 0.01), while nicotine delivery did not differ significantly. The CPE of IQOS was greater in the IQOS-M group than in the IQOS-T group (0.8 versus 0.0; p = 0.03), indicating greater substitutability. Menthol glucuronide boosts were positively associated with CPE (τ=0.32, p = 0.03), whereas nicotine boosts were not significantly associated (τ=0.19, p = 0.20).
Conclusions:
IQOS can deliver high levels of menthol, and menthol delivery predicted willingness to substitute this heated tobacco product for menthol cigarettes. These findings highlight the importance of non-nicotine constituents in shaping abuse liability and have direct implications for the regulation of tobacco products.
More Related Videos
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Phase Transitions: Vaporization and Condensation
Predicting Products: Substitution vs. Elimination
The following factors can influence the mechanisms competing against each other:
Phase Transitions: Sublimation and Deposition

